Overview


According to FutureWise analysis the market for Unit drug dose delivery system is expected to register a CAGR of 6.00% from 2023-2031.

Hospitals and clinics use unit drug dose delivery systems for accurate dosing, owing to the ease of storage, accurate dosing, and ease of disposal they allow.
The driving force for the unit drug dose delivery systems globally is the rise in demand for prefilled syringes among patient population. With pharmaceuticalsand healthcare industries growing at a higher rate. This market is expected to experience huge growth in the near future. Key market players are expanding their production capabilities and also enhancing their global reach to cementtheir position in the market.

Increasing importance of patient-specific drug distribution system to minimize dosage errors led to the robust growth of the market. It is a convenient alternative over traditional methods and increases patient compliance adherence during the treatment of various indications. They are proven reliable safe and decrease the total cost of both manufacturing
treatment. Unit dose allows drug use monitoring and control misuse of medication during disease management. Further, unit dose offers greater adaptability with the automated process in dispensing and increase the efficiency. Along with this, changing regulations to control the dose errors have to lead to the rapid growth of the market. Healthcare systems considered unit dispensing as an essential part of drug distribution and increased opportunities for manufacturers. Other factors like changing socio-demographics and increasing awareness among the general population have created potential growth opportunities for manufacturers.

North America is a major shareholder in the global market due to high penetration among the general population. Europe is a second major shareholder in the global market due to supportive regulatory conditions. The the Asia Pacific, Latin America regions are expected to witness the highest growth rate due to a large number of the patient group and the high prevalence of the chronic disease. Latin America and Rest of world regions are expected to account a small share in the global market and expected to gain more traction during the forecast period due to increasing adoption.

  • Mylan N.V.
  • Amedra Pharmaceuticals LLC
  • Owen Mumford
  • Ypsomed AG
  • Antares Pharma
  • SHL Group
  • Johnson & Johnson

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Material Type

  • Plastic
    • Polyethylene (PE)
      • High Density Polyethylene (HDPE)
      • Low Density Polyethylene (LDPE)
    • oly Vinyl Chloride (PVC)P
    • Polystyrene
    • Polycarbonate
    • Polypropylene
    • Polyethylene Terephthalate (PET)
  • Glass
    • Type 1
    • Type 2
    • Type 3
    • Others

By Product Type

  • Solid
  • Liquid
  • Powder

By End User

  • Hospitals
  • Clinics
  • Outpatient Centres

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Unit Drug Dose Delivery System Market by Product Type, by End-User and by Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

 

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Unit Drug Dose Delivery System Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Unit Drug Dose Delivery System Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Unit Drug Dose Delivery System Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Unit Drug Dose Delivery System Market, By Material Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Plastic
         1.1. Polyethylene (PE)
          1.1.1. High Density Polyethylene (HDPE)
          1.1.2. Low Density Polyethylene (LDPE)
         1.2. oly Vinyl Chloride (PVC)P
         1.3. Polystyrene
         1.4. Polycarbonate
         1.5. Polypropylene
         1.6. Polyethylene Terephthalate (PET)
        2. Glass
         2.1. Type 1
         2.2. Type 2
         2.3. Type 3
         2.4. Others

  • 8.   Unit Drug Dose Delivery System Market, by Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Solid
        2. Liquid
        3. Powder

  • 9.   Unit Drug Dose Delivery System Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Outpatient Centres

  • 10.   North America Unit Drug Dose Delivery System Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Unit Drug Dose Delivery System Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Unit Drug Dose Delivery System Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Unit Drug Dose Delivery System Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Mylan N.V.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Amedra Pharmaceuticals LLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Owen Mumford
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Ypsomed AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Antares Pharma
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. SHL Group
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Johnson & Johnson
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients